VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML | MicrobiomeTrials← Back to trialsNCT07635485
VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2029-05-31
Enrollment target: 50 participants Locations- The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Other microbiome trials you might be interested in
Myeloid MalignancyGenetic Predisposition to DiseaseMyeloid Hematological Malignancies
The goal of this research study is to evaluate the feasibility of germline genetic testing using the investigational Mye…
Boston, United StatesEst. completion Apr 1, 2030
Acute LeukemiaAdenomatous PolyposisAdrenocortical CarcinomaAMLBAP1 Tumor Predisposition SyndromeCarney ComplexChoroid Plexus CarcinomaConstitutional Mismatch Repair Deficiency Syndrome
Diamond-Blackfan Anemia
DICER1 Syndrome
Dyskeratosis Congenita
Emberger Syndrome
Familial Acute Myeloid Leukemia
Familial Adenomatous Polyposis
Fanconi Anemia
Familial Cancer
Familial Wilms Tumor
Familial Neuroblastoma
GIST
Hereditary Breast and Ovarian Cancer
Hereditary Paraganglioma-Pheochromocytoma Syndrome
Hodgkin Lymphoma
Juvenile Polyposis
Li-Fraumeni Syndrome
Lynch Syndrome
MDS
Melanoma Syndrome
Multiple Endocrine Neoplasia Type 1
Multiple Endocrine Neoplasia Type 2
Neuroblastoma
Neurofibromatosis Type 1
Neurofibromatosis Type II
Nevoid Basal Cell Carcinoma Syndrome
Non Hodgkin Lymphoma
Noonan Syndrome and Other Rasopathy
Overgrowth Syndromes
Pancreatic Cancer
Peutz-Jeghers Syndrome
Pheochromocytoma/Paraganglioma
PTEN Hamartoma Tumor Syndrome
Retinoblastoma
Rhabdoid Tumor Predisposition Syndrome
Rhabdomyosarcoma
Rothmund-Thomson Syndrome
Tuberous Sclerosis
Von Hippel-Lindau Disease
NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never rece…
Memphis, United StatesEst. completion Mar 31, 2037